CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 767.00
-7.00 (-0.90%)
Oct 6, 2026, 3:30 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 14.66 billion as of October 5, 2026. Its market cap has decreased by -26.04% in one year.
Market Cap
14.66B
Enterprise Value
13.21B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
767.00
ChartMarket Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 14.66B, an increase of 74.87%. That is a compound annual growth rate of 3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 14.66B | -4.48% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 15.85B |
| Stella Pharma | 15.78B |
| AnGes | 13.96B |
| ReproCELL | 13.71B |
| Kubota Pharmaceutical Holdings | 10.86B |
| Immuno-Biological Laboratories | 10.66B |
| StemRIM | 10.28B |
| Carna Biosciences | 8.80B |